Стоимость чистых активов31.05.2024 Изменение0.0000 Тип доходности Инвестиционная направленность Инвестиционная компания
4.6700SGD 0.00% reinvestment Equity Sector Health / Pharma Invesco Management 

Инвестиционная стратегия

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Fund may use derivatives (complex instruments) to manage the Fund more efficiently, with the aim of reducing risk, reducing costs and/or generating additional capital or income. The Fund is actively managed and is not constrained by its benchmark, MSCI China A Onshore Health Care Index, which is used for comparison purposes. However, as the benchmark is a suitable proxy for the investment strategy, it is likely that some of the Fund"s holdings are also components of the benchmark. As an actively managed fund, this overlap will change and this statement may be updated from time to time.
 

Инвестиционная цель

The objective of the Fund is to achieve long term capital growth. The Fund invests in Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect as well as those listed or traded elsewhere, included Qualified Foreign Investors (QFI). The Fund invests in companies which are attractively valued and demonstrate sustainable growth, along with a strong business model and sound balance sheet. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.
 

Основные данные

Тип доходности: reinvestment
Категории фондов: Equity
Страна: China
Branch: Sector Health / Pharma
Бенчмарк: MSCI China A Onshore Health Care Index
Начало рабочего (бизнес) года: 29.02
Last Distribution: -
Депозитарный банк: -
Место жительства фонда: Luxembourg
Разрешение на распространение: Austria, Germany, Switzerland
Управляющий фондом: Chris Liu, Kehong Jiang
Объем фонда: 486.11 млн  EUR
Дата запуска: 15.12.2020
Инвестиционная направленность: -

Условия

Эмиссионная надбавка: 5.00%
Max. Administration Fee: 1.00%
Минимальное вложение: 1,200,000.00 SGD
Deposit fees: 0.01%
Комиссионные, взимаемые фондами взаимных инвестиций при погашении акций: 0.00%
Упрощенный проспект: Скачать (Версия для печати)
 

Инвестиционная компания

Товарищества на вере: Invesco Management
Адрес: An der Welle 5, 60322, Frankfurt am Main
Страна: Germany
Интернет: www.de.invesco.com
 

Активы

Stocks
 
96.91%
Cash
 
3.09%

Страны

China
 
65.14%
Cash
 
3.09%
Cayman Islands
 
3.05%
Другие
 
28.72%

Отрасли

Pharma/Biotechnology
 
50.29%
Healthcare appliances
 
14.53%
Healthcare services
 
3.36%
Cash
 
3.09%
Другие
 
28.73%